Astrea Bioseparations

Our industry-leading bioseparation technologies empower our customers to deliver life-improving and life-saving advanced therapies to patients worldwide. With a legacy of over 30 years, our team takes pride in supplying world-class products that adhere to FDA and EMA standards, ensuring excellence in manufacturing processes. At the heart of our commitment is a dedicated R&D team relentlessly driving innovation, bringing state-of-the-art technologies to market. In an ever-evolving landscape, we strive to meet the dynamic needs for speed and efficiency. Explore the pinnacle of bioseparation excellence with Astrea Bioseparations, a Biotage company, where every breakthrough propels us towards a future of enhanced patient care.

Since 1987, Astrea Bioseparations has been pioneering the design, development and manufacture of affinity purification technology for lab-scale and industrial-scale bioprocessing. With over 25 years experience and success in the development of affinity products and design of new custom adsorbents, Astrea is a world leader in its field. Astrea Bioseparations has sales and support offices in North America and Europe, R&D facilities in Cambridge, UK and manufacturing facilities located on the Isle of Man, British Isles and Joliette, QC, Canada ensuring that we are able to meet your needs and support your application wherever you are.

OUR EXPERTISE:

• Extensive range of bioseparation products
• Custom designed chromatography adsorbents
• Over 25 years experience & success
• Cost effective solutions
• Proven Mimetic Ligand™ technology
• Dedicated professional service
• Full technical support & in-house training
• Experts in adsorbent development & downstream process optimization
• Established manufacturing facility (ISO 9001)

• Small molecules
• Immunology/inflammation
• Medical Devices
• Gastrointestinal Tract
• Blood
• Diabetes
• Eye Health
• Autoimmune diseases
• Respiratory System
• Metabolic Disorders
• Endocrinology